Recent REPROCELL News

News Items by Topic

REPROCELL News

REPROCELL is pleased to announce that the first patient has been registered and the test article administered at Nagoya University in the Phase II clinical trial of the regenerative medicine product Stemchymal®.

Continue reading →

Clinical Capabilities


Recent REPROCELL News

News Items by Topic